Innoviva, Inc.

Insider Reports History

Location
Burlingame, CA
Signature
INNOVIVA, INC. By: /s/ Pavel Raifeld Name: Pavel Raifeld Title: Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Innoviva, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Armata Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 16,365,969 $81,829,845 $5.00 31 Mar 2022 Indirect
Entasis Therapeutics Holdings Inc. 10%+ Owner Common Stock 29,270,476 $64,395,047 $2.20 11 Jul 2022 Indirect
Armata Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 8,710,800 $43,554,000 $5.00 31 Mar 2022 Direct
Armata Pharmaceuticals, Inc. Director, 10%+ Owner Warrants to Purchase Common Stock 8,710,800 $43,554,000 $5.00 31 Mar 2022 Direct
Entasis Therapeutics Holdings Inc. 10%+ Owner Common Stock 18,672,897 $41,080,373 $2.20 08 Jul 2022 Direct
Entasis Therapeutics Holdings Inc. 10%+ Owner Warrants to Purchase Common Stock 18,672,897 $37,345,794 $2.00 08 Jul 2022 Direct
Entasis Therapeutics Holdings Inc. 10%+ Owner Warrants to Purchase Common Stock 10,000,000 $20,000,000 $2.00 08 Jul 2022 Indirect
Armata Pharmaceuticals, Inc. Director, 10%+ Owner Warrants to Purchase Common Stock 2,692,604 $13,463,020 $5.00 31 Mar 2022 Indirect
Entasis Therapeutics Holdings Inc. 10%+ Owner Convertible Promissory Note 0 08 Jul 2022 Indirect
Armata Pharmaceuticals, Inc. Director, 10%+ Owner Convertible Debt convertible into Common Stock $30,000,000 10 Jan 2023 Indirect

Insider Reports Filed by Innoviva, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARMP Armata Pharmaceuticals, Inc. 10 Jan 2023 1 +$30,000,000 4 Director, 10%+ Owner 12 Jan 2023, 20:21
/report/000114036122025957-innoviva-inc-2022-07-08 Entasis Therapeutics Holdings Inc. 08 Jul 2022 2 +$42,395,047 4 10%+ Owner 13 Jul 2022, 21:27
ARMP Armata Pharmaceuticals, Inc. 31 Mar 2022 2 +$26,926,040 4 Director, 10%+ Owner 01 Apr 2022, 16:52
/report/000156761922005338-innoviva-inc-2022-02-18 Entasis Therapeutics Holdings Inc. 18 Feb 2022 2 $0 4 10%+ Owner 23 Feb 2022, 12:05
ARMP Armata Pharmaceuticals, Inc. 09 Feb 2022 2 +$27,110,940 4 Director, 10%+ Owner 11 Feb 2022, 17:56
ARMP Armata Pharmaceuticals, Inc. 29 Oct 2021 1 +$4,000,003 4 Director, 10%+ Owner 01 Nov 2021, 14:20
/report/000156761921012030-innoviva-inc-2021-06-11 Entasis Therapeutics Holdings Inc. 11 Jun 2021 2 +$25,075,900 4 10%+ Owner 11 Jun 2021, 17:39
/report/000156761921010772-innoviva-inc-2021-05-03 Entasis Therapeutics Holdings Inc. 03 May 2021 2 +$14,924,100 4 10%+ Owner 20 May 2021, 14:39